Such relationships will help demonstrate the benefits of this approach and ultimately lead to adoption of process intensification when it is the most effective solution,” Poechlauer concludes. At the ...

“The reduced size and cost of continuous manufacturing equipment together with the ability to adjust output by numbering out and numbering up will enable responsive supply chains for pharmaceutical ...

Sterling to make API in flow process by Michael McCoy October 13, 2024 | A version of this story appeared in Volume 102, Issue 32 Credit: Sterling Pharma Solutions ...

When transparent channels for communication are put in place, the sponsor receives frequent updates on the manufacturing process instead of waiting weeks or months to identify progress.

The global pharmaceutical API manufacturing market is expected to grow from $179.05 billion in 2021 to $195.29 billion in 2022 at a compound annual growth rate (CAGR) of 9.1%.

Wuxi STA, a subsidiary of WuXi AppTec, continued its manufacturing expansion march with the opening of another high-potency active pharmaceutical ingredient (HPAPI) production facility in China ...